U.S. markets closed
  • S&P Futures

    3,272.75
    -29.50 (-0.89%)
     
  • Dow Futures

    26,373.00
    -184.00 (-0.69%)
     
  • Nasdaq Futures

    11,201.00
    -141.75 (-1.25%)
     
  • Russell 2000 Futures

    1,547.80
    -10.60 (-0.68%)
     
  • Crude Oil

    36.48
    +0.31 (+0.86%)
     
  • Gold

    1,874.50
    +6.50 (+0.35%)
     
  • Silver

    23.53
    +0.17 (+0.75%)
     
  • EUR/USD

    1.1693
    +0.0015 (+0.13%)
     
  • 10-Yr Bond

    0.8350
    +0.0540 (+6.91%)
     
  • Vix

    37.59
    -2.69 (-6.68%)
     
  • GBP/USD

    1.2937
    +0.0014 (+0.11%)
     
  • USD/JPY

    104.4500
    -0.1600 (-0.15%)
     
  • BTC-USD

    13,535.81
    +105.14 (+0.78%)
     
  • CMC Crypto 200

    265.25
    +22.57 (+9.30%)
     
  • FTSE 100

    5,581.75
    -1.05 (-0.02%)
     
  • Nikkei 225

    23,148.75
    -183.19 (-0.79%)
     

Does Market Volatility Impact NeuroMetrix, Inc.'s (NASDAQ:NURO) Share Price?

Simply Wall St
·3 mins read

If you're interested in NeuroMetrix, Inc. (NASDAQ:NURO), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. Volatility is considered to be a measure of risk in modern finance theory. Investors may think of volatility as falling into two main categories. The first type is company specific volatility. Investors use diversification across uncorrelated stocks to reduce this kind of price volatility across the portfolio. The second type is the broader market volatility, which you cannot diversify away, since it arises from macroeconomic factors which directly affects all the stocks on the market.

Some stocks are more sensitive to general market forces than others. Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). However, Warren Buffett said 'volatility is far from synonymous with risk' in his 2014 letter to investors. So, while useful, beta is not the only metric to consider. To use beta as an investor, you must first understand that the overall market has a beta of one. A stock with a beta greater than one is more sensitive to broader market movements than a stock with a beta of less than one.

Check out our latest analysis for NeuroMetrix

What we can learn from NURO's beta value

Zooming in on NeuroMetrix, we see it has a five year beta of 1.39. This is above 1, so historically its share price has been influenced by the broader volatility of the stock market. If the past is any guide, we would expect that NeuroMetrix shares will rise quicker than the markets in times of optimism, but fall faster in times of pessimism. Beta is worth considering, but it's also important to consider whether NeuroMetrix is growing earnings and revenue. You can take a look for yourself, below.

NasdaqCM:NURO Income Statement April 15th 2020
NasdaqCM:NURO Income Statement April 15th 2020

Does NURO's size influence the expected beta?

With a market capitalisation of US$4.4m, NeuroMetrix is a very small company by global standards. It is quite likely to be unknown to most investors. Relatively few investors can influence the price of a smaller company, compared to a large company. This could explain the high beta value, in this case.

What this means for you:

Since NeuroMetrix has a reasonably high beta, it's worth considering why it is so heavily influenced by broader market sentiment. For example, it might be a high growth stock or have a lot of operating leverage in its business model. This article aims to educate investors about beta values, but it's well worth looking at important company-specific fundamentals such as NeuroMetrix’s financial health and performance track record. I highly recommend you dive deeper by considering the following:

  1. Future Outlook: What are well-informed industry analysts predicting for NURO’s future growth? Take a look at our free research report of analyst consensus for NURO’s outlook.

  2. Past Track Record: Has NURO been consistently performing well irrespective of the ups and downs in the market? Go into more detail in the past performance analysis and take a look at the free visual representations of NURO's historicals for more clarity.

  3. Other Interesting Stocks: It's worth checking to see how NURO measures up against other companies on valuation. You could start with this free list of prospective options.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.